In The News

  • Pink Shirt Day: Bullying’s Mental Health Focus

    Pink Shirt Day, celebrated annually in Canada and across the globe, stands as a vibrant testament to the collective resolve against bullying—a pervasive issue that transcends the confines of playgrounds and permeates schools, workplaces, homes, and the digital realm. Originating from a Canadian act of solidarity when two students, Travis Price and David Shepherd, rallied their peers to don pink shirts in support of a fellow student bullied for wearing pink, the day has evolved into a global movement. It underscores the importance of community action in confronting bullying, advocating for kindness, and fostering environments where respect and empathy prevail. This initiative not only highlights the social and emotional toll…

  • Breakthrough Blood Test for Alzheimer’s

    In the continuously evolving and ever-expansive landscape of medical diagnostics, particularly in the domain of neurodegenerative diseases, a recent groundbreaking study has emerged, offering a beacon of hope for the early detection and, consequently, more effective management of Alzheimer’s disease. Central to this pivotal research is the innovative utilization of a blood test, specifically designed to detect the presence of a specific protein, known in the medical community as phosphorylated tau or p-tau. This development is not merely an incremental advancement; it represents a potential paradigm shift in our approach to diagnosing Alzheimer’s, promising not just early detection but also heralding a more accessible, cost-effective alternative to the traditional, more…

  • The Efficacy of DASH and MIND Diets

    In the dynamic field of nutritional science, a recent evaluative study of 30 diverse diets has notably positioned the DASH diet, an acronym for Dietary Approaches to Stop Hypertension, as the second most effective, closely followed by the MIND diet, formally known as the Mediterranean-DASH Intervention for Neurodegenerative Delay, ranked third. This prominent placement underscores the increasing recognition within the medical community of the substantial influence dietary habits exert on overall health, particularly in cardiovascular and cognitive domains. The DASH diet, originally formulated to address hypertension, adopts an integrative nutritional strategy, prioritizing the intake of fruits, vegetables, and whole grains, and incorporating beans and seeds. Its core principle involves a…

  • The Risks of Repeated COVID-19 Infections

    According to a new report from the World Health Organization (WHO) it has emerged that the actual levels of COVID-19 cases globally could be significantly higher – ranging from 2 to 19 times more than the reported figures. This revelation is based on comprehensive wastewater data analysis. This finding is particularly alarming as it underscores the potential underestimation of the virus’s prevalence, raising questions about the global response and readiness against the pandemic. Adding to the complexities of the pandemic, the WHO is highlighting the largely unknown dangers of repeated COVID-19 infections, which can frequently occur without any symptoms. This aspect of the virus’s behavior is particularly insidious, as it…

  • What is Medulloblastoma?

    Medulloblastoma, a formidable adversary in the realm of brain cancers, has recently cast its shadow over a well-known family, touching the life of Isabella Strahan, the daughter of Michael Strahan, co-host on ABC’s ‘Good Morning America’ and former NFL player. This revelation not only spotlights Isabella’s personal battle but also brings to the forefront a critical understanding of Medulloblastoma, a condition that remains shrouded in complexity and challenges. At its core, Medulloblastoma is a type of brain tumour predominantly found in children, although its occurrence is not entirely exclusive to the younger population. It originates in the cerebellum, the part of the brain responsible for coordinating movement. This cancer, while…

  • Unanimous Vote for XBB-Centric COVID-19 Vaccine

    Moderna, Pfizer-BioNTech, and Novavax, key vaccine manufacturers, have presented evidence before the U.S. Food and Drug Administration’s (FDA) vaccine committee, illustrating that their experimental vaccines induce similarly potent antibody responses against the XBB.1.5 and XBB.1.16 variants of the virus. Furthermore, they have demonstrated that these vaccines also show efficacy against other emerging variants like XBB.2.3. The genetic differences among these XBB strains, according to these manufacturers, are negligible — limited to just two or three modifications. This implies that, from the perspective of the immune system, these variants are nearly identical. Given this data, the FDA’s 21-member vaccine committee unanimously proposed an overhaul of the existing COVID-19 vaccine, moving from…